Bismuth/ofloxacin combination for duodenal ulcer.

Suppr

超能文献

作者信息

Bayerdörffer E, Simon T, Bästlein C, Ottenjann R, Kasper G

出版信息

Lancet. 1987 Dec 19;2(8573):1467-8. doi: 10.1016/s0140-6736(87)91169-x.

DOI:10.1016/s0140-6736(87)91169-x

PMID:2892030

Abstract

摘要

相似文献

Bismuth/ofloxacin combination for duodenal ulcer.

Lancet. 1987 Dec 19;2(8573):1467-8. doi: 10.1016/s0140-6736(87)91169-x.

[Effect of bismuth subsalicylate versus cimetidine on Campylobacter pylori, ulcer healing and rate of recurrence].

Med Klin (Munich). 1988 May 27;83(12):402-5.

[Ofloxacin in the therapy of Campylobacter pylori-positive duodenal ulcer. A prospective controlled randomized study].

Dtsch Med Wochenschr. 1987 Sep 11;112(37):1407-11. doi: 10.1055/s-2008-1068260.

[Prevention of recurrence with bismuth subsalicylate in a patient with recurrent and H2 receptor antagonist refractory duodenal ulcer].

Internist (Berl). 1989 Jun;30(6):390-2.

[Morphologic change in Campylobacter pylori associated gastritis in and following successful antibacterial therapy].

Pathologe. 1989 Jan;10(1):64-5.

Colloidal bismuth subcitrate (DE-NOL) and tinidazole healed duodenal ulceration with a low relapse rate due to elimination of Campylobacter pylori.

J Chemother. 1989 Jul;1(4 Suppl):838-9.

Omeprazole/amoxicillin versus ranitidine/triple therapy for duodenal ulcer: when is the "same" the same?

Am J Gastroenterol. 1994 Jun;89(6):947-8.

[Therapy of peptic ulcer and chronic gastritis with bismuth salts].

Z Gastroenterol. 1987 Sep;25 Suppl 4:34-40.

[Dose-effect studies with bismuth salts for the elimination of Campylobacter pylori].

Z Gastroenterol. 1987 Sep;25 Suppl 4:44-6.

[Ofloxacin in therapy of "resistant" duodenal ulcer. A pilot study].

Z Gastroenterol. 1988 Mar;26(3):155-9.

引用本文的文献

One-day high-dose combined therapy of Helicobacter pylori infection.

Dig Dis Sci. 1997 Oct;42(10):2169-70. doi: 10.1023/a:1018851425080.

One-day therapy for treatment of Helicobacter pylori infection.

Dig Dis Sci. 1993 Sep;38(9):1670-3. doi: 10.1007/BF01303176.

Susceptibility of clinical isolates of Campylobacter pylori to twenty-one antimicrobial agents.

Eur J Clin Microbiol Infect Dis. 1988 Aug;7(4):566-9. doi: 10.1007/BF01962617.

Fluoroquinolone antibiotics. Microbiology, pharmacokinetics and clinical use.

Drugs. 1988 Aug;36(2):193-228. doi: 10.2165/00003495-198836020-00004.

Colloidal bismuth subcitrate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease.

Drugs. 1988 Aug;36(2):132-57. doi: 10.2165/00003495-198836020-00002.

Quinolones and the gastrointestinal tract.

Eur J Clin Microbiol Infect Dis. 1989 Dec;8(12):1093-101. doi: 10.1007/BF01975176.

Fluoroquinolone antimicrobial agents.

Clin Microbiol Rev. 1989 Oct;2(4):378-424. doi: 10.1128/CMR.2.4.378.

Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases.

Drugs. 1989 Jun;37(6):801-70. doi: 10.2165/00003495-198937060-00003.

Adjuvant antibiotic therapy in duodenal ulcers treated with colloidal bismuth subcitrate.

Gut. 1990 Sep;31(9):999-1002. doi: 10.1136/gut.31.9.999.

Ofloxacin. A reappraisal of its antimicrobial activity, pharmacology and therapeutic use.

Drugs. 1991 Nov;42(5):825-76. doi: 10.2165/00003495-199142050-00008.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验